DONALD L. ST. GERMAIN, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Solomon and associates (1) recently reported that the rate of remission in patients with Graves disease treated with antithyroid drugs since 1973 at their center in Washington, D.C. was approximately 50%. Although this finding is of interest, the authors' reliance on the studies of Park and associates (2) and Pennington and coworkers (3, 4) to support their speculation that this high remission rate may be due to a decrease in dietary iodine intake is inappropriate and misleading for two reasons.
First, the data on iodine intake cited by the authors, and presented in the lower portion of
GERMAIN DLS. Remission of Graves Disease and Iodine Intake. Ann Intern Med. ;108:482–483. doi: 10.7326/0003-4819-108-3-482_3
Download citation file:
Published: Ann Intern Med. 1988;108(3):482-483.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use